Insulin receptor substrate (IRS) proteins play a central role in signal transduction by the receptors for insulin, insulin-like growth factor 1 (IGF-1), and a growing number of cytokines and integrins (19, 34, 58) . IRS proteins are composed of an NH 2 -terminal pleckstrin homology (PH) domain and a phosphotyrosine binding (PTB) domain, followed by a COOHterminal tail containing multiple tyrosine phosphorylation motifs (48). The PH and PTB domains are well conserved in each IRS protein and have a common tertiary structure but function differently to couple IRS proteins to the activated insulin receptor (10, 26, 57) . PH domains are thought to bind membrane phospholipids or acidic motifs of various proteins, whereas the PTB domain interacts with the phosphorylated NPEY motif in the juxtamembrane region of the insulin receptor ␤-subunit; both interactions promote tyrosine phosphorylation of multiple tyrosine residues in the COOH terminus. The COOH terminus is poorly conserved among the IRS proteins; in IRS-1 (the first cloned and best-characterized IRS protein) it contains 18 potential tyrosine phosphorylation sites in amino acid sequence motifs that directly bind to Src homology-2 domains in several proteins, including phosphatidylinositol (PI) 3-kinase regulatory subunits (p85␣, p55␣ p50␣, p85␤, and p55 PIK ), Grb-2, Nck, c-fyn, and SHP-2 (58). The other IRS proteins contain common and unique phosphorylation motifs, suggesting that they mediate overlapping and distinct biological signals. One region of predicted overlap in the signals mediated by IRS-1, IRS-2, and IRS-4 is the binding and activation of PI 3-kinase; a conspicuous example of dissimilarity is the absence of SHP-2 binding motifs in IRS-4.
Insulin receptor substrate (IRS) proteins play a central role in signal transduction by the receptors for insulin, insulin-like growth factor 1 (IGF-1), and a growing number of cytokines and integrins (19, 34, 58) . IRS proteins are composed of an NH 2 -terminal pleckstrin homology (PH) domain and a phosphotyrosine binding (PTB) domain, followed by a COOHterminal tail containing multiple tyrosine phosphorylation motifs (48) . The PH and PTB domains are well conserved in each IRS protein and have a common tertiary structure but function differently to couple IRS proteins to the activated insulin receptor (10, 26, 57) . PH domains are thought to bind membrane phospholipids or acidic motifs of various proteins, whereas the PTB domain interacts with the phosphorylated NPEY motif in the juxtamembrane region of the insulin receptor ␤-subunit; both interactions promote tyrosine phosphorylation of multiple tyrosine residues in the COOH terminus. The COOH terminus is poorly conserved among the IRS proteins; in IRS-1 (the first cloned and best-characterized IRS protein) it contains 18 potential tyrosine phosphorylation sites in amino acid sequence motifs that directly bind to Src homology-2 domains in several proteins, including phosphatidylinositol (PI) 3-kinase regulatory subunits (p85␣, p55␣ p50␣, p85␤, and p55 PIK ), Grb-2, Nck, c-fyn, and SHP-2 (58) . The other IRS proteins contain common and unique phosphorylation motifs, suggesting that they mediate overlapping and distinct biological signals. One region of predicted overlap in the signals mediated by IRS-1, IRS-2, and IRS-4 is the binding and activation of PI 3-kinase; a conspicuous example of dissimilarity is the absence of SHP-2 binding motifs in IRS-4.
PI 3-kinase is a heterodimeric signaling enzyme composed of a catalytic subunit (p110) associated with an SH2 domaincontaining regulatory subunit (e.g., p55
PIK , p85␣, and p85␤) that binds to tyrosine-phosphorylated YXXM motifs on signaling proteins. Since all of the IRS proteins contain numerous YXXM motifs, they are all expected to bind and activate p85-associated PI 3-kinase. The lipid products of PI 3-kinase mediate the activation of several serine/threonine kinases, including PDK1/PDK2, protein kinase B (PKB)/Akt, PKC and PKC, p70 s6k , and others (3, 29, 32, 52, 53) . These serine/ threonine kinases play various roles in the regulation of the many biological responses linked to the activation of PI 3-kinase, including activation of glucose transport and glycogen synthesis, protein synthesis, lipogenesis and antilipolysis, and mitogenesis and antiapoptosis (12, 14, 16, 22, 38) .
In vivo and in vitro experiments reveal important differences in the signaling capacity of IRS-1 and IRS-2. IRS-1 and IRS-2 display differential sensitivities for binding various SH2 proteins (46) . Moreover, IRS-2 expressed in fibroblasts lacking IRS-1 does not reconstitute normal insulin-IGF-1 signaling (9) . Mice lacking IRS-1 are small and mildly insulin resistant but never develop diabetes (5) . In contrast, mice lacking IRS-2 are insulin resistant with abnormal glucose tolerance at birth and progressively develop fasting hyperglycemia with reduced ␤-cell mass (54; D. J. Withers, D. J. Burks, H. H. Towery, S. L. Altamuro, C. L. Flint, and M. F. White, unpublished data). Together, these results suggest that IRS-2 is critical for normal carbohydrate metabolism and that IRS-1 is important for somatic cell growth (55) . Previous results suggest that IRS-4 has similar signaling potential to IRS-1 and IRS-2; however, our results with 32D
IR cells revealed that IRS-4 activates PKB/Akt and promotes BAD phosphorylation without the activation of p70 s6k or the inhibition of apoptosis. These differences might have important consequences for the specific tissues that express IRS-4.
MATERIALS AND METHODS

Cloning of human IRS-4.
To isolate the gene encoding IRS-4, a 540-bp DNA fragment of IRS-4 was amplified by RT-PCR with total RNA extracted from HEK293 cells. The sense and antisense primers were 5Ј-CCGCTCGAGCCGG GAGGCT-3Ј (nucleotides 1171 to 1193) and 5Ј-ATCTCTAGAGCACTGGTT TC-3Ј (nucleotides 1703 to 1722), respectively. The nucleotide numbers used here correspond to the numbering used by Lavan et al. (24) . This DNA fragment was labeled with [␣-32 P]dCTP and used to screen a human fibroblast genomic library (Stratagene). Four independent clones were obtained, and a 4.5-kb portion of EcoRI DNA fragment was subcloned into pBluescript II for subsequent sequencing. Sequence analysis revealed that human IRS-4 had no introns like IRS-1 and IRS-2 and that this EcoRI fragment contained the full length of the coding region.
Cell culture. 32D cell lines were cultured in RPMI 1640 containing 10% fetal bovine serum (FBS) and 5% WEHI-3-conditioned RPMI 1640 medium as a source of interleukin-3 (IL-3). 32D
IR cells expressing IRS-1, IRS-2, or IRS-4 cell lines were maintained in the same medium containing, in addition, 5 mM histidinol (Bachem Bioscience, Inc.). HEK293 cells were cultured in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% FBS.
Generation of 32D cell line. 32D IR cells and 32D IR cells expressing IRS-1 and IRS-2 are described elsewhere (48) . A 4.5-kb EcoRI fragment of IRS-4 was inserted into pCMV his expression vector, and then 10 g of purified vector was used to transfect 5 ϫ 10 6 32D IR cells by electroporation. Antibiotic-resistant cells were selected in the RPMI 1640 containing 5 mM histidinol for 10 days. Resistant colonies were then expanded and screened for protein expression by Western blotting.
Immunoprecipitation and immunoblotting. Anti-IRS-4 polyclonal antibodies were raised against the carboxyl-terminal 17 amino acids of human IRS-4 (MD-FARRDNQFDSPKRGR) coupled to keyhole limpet hemocyanin. The antibodies immunoprecipitated and immunoblotted both endogenous and recombinant IRS-4 from HEK293 cells and 32D IR /IRS-4 cells without any cross-reactivity with IRS-1 or IRS-2 (data not shown). Phospho-PKB/Akt polyclonal antibodies and phospho-BAD polyclonal antibodies (Ser112) were purchased from New England Biolabs (numbers 9271 and 9291, respectively). PY20 monoclonal antiphosphotyrosine antibody was purchased from Transduction Laboratories (P11120). Polyclonal or monoclonal antibodies against Grb-2 (C-23), PKB/Akt (C-20), BAD (C-20), 14-3-3 (H-8), and Bcl-2 (C-2) were purchased from Santa Cruz Biotechnology. Polyclonal antibodies against insulin receptor, p85 PI 3-K pan , p85 PI 3-K␣, p85 PI 3-K␤, mitogen-activated protein kinase (MAPK), and p70 s6k were as described elsewhere (59) . Each cell line (10 8 cells) was serum starved in 10 ml of RPMI 1640 in a 50-ml conical tube for 4 h. The cells were treated with or without insulin, and ice-cold phosphate-buffered saline (PBS) was added to stop the reaction. The cells were collected by centrifugation and then lysed in 1 ml of TNE lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% NP-40, 5 mM EDTA, 5% glycerol, 10 g leupeptin per ml, 10 g of aprotinin per ml, 1 mM phenylmethylsulfonyl fluoride [PMSF] , and 2 mM sodium vanadate). Then, 10-mm plates of HEK293 cells were serum starved in 10 ml of DMEM for 4 h, treated with or without insulin, and lysed as described above. Insoluble material was removed by centrifugation, and the resulting supernatants were subjected to immunoprecipitation at 4°C for 2 h. Immune complex was collected and washed with TNE lysis buffer three times and then resuspended in 2 ϫ sodium dodecyl sulfate (SDS) sample buffer. Proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to Protran nitrocellulose membrane (Schleicher & Schuell). The blots were blocked with 5% skim milk in TBST buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 0.05% Tween 20) and then incubated with antibodies in TBST containing 2% bovine serum albumin (BSA), followed by incubation with either secondary antibodies conjugated to horseradish peroxidase or 125 I-protein A. The immunoreactive bands were visualized by either enhanced chemiluminescence or a Bio-Rad Molecular Imager.
PI 3-kinase assay. 32D cell lines treated with or without insulin for 1 min were lysed in 1 ml of PI 3-kinase lysis buffer (20 mM Tris-HCl [pH 7.4], 137 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10% glycerol, 1% NP-40, 10 g of leupeptin per ml, 10 g of aprotinin per ml, 1 mM PMSF, and 2 mM sodium vanadate) and immunoprecipitated. The resulting immune complex was washed with PBS containing 1% NP-40 and 2 mM sodium vanadate (three times); 100 mM Tris-HCl (pH 7.4) containing 500 mM LiCl and 2 mM sodium vanadate (three times); and 10 mM Tris-HCl containing 100 mM NaCl, 1 mM EDTA, and 1 mM sodium vanadate (twice). The pellets were resuspended in 60 l of 10 mM Tris-HCl (pH 7.4) containing 100 mM NaCl and 1 mM EDTA and then combined with 10 l of 100 mM MgCl 2 and 10 l of a 2-g/ml concentration of PI (Avanti) sonicated in 10 mM Tris-HCl (pH 7.4) containing 1 mM EGTA. The phosphorylation reaction was started by adding 5 l of 65 M ATP containing 3 Ci of [␥-32 P]ATP. After 15 min at room temperature, the reaction was stopped with 20 l of 8 N HCl and 160 l of CHCl 3 -methanol (1:1). The samples were centrifuged, and the lower organic phase was applied to a silica gel thin-layer chromatography (TLC) plate (Merck). TLC plates were developed in CHCl 3 -CH 3 OH-H 2 O-NH 4 OH (60:47:11.3:2), dried, and visualized and quantified on a Bio-Rad Molecular Imager.
PKB/Akt kinase activity assay. 32D cell lines were serum starved 4 h, followed by stimulation with 100 nM insulin for 30 min. Cells were lysed in 1 ml of Akt lysis buffer (20 mM Tris-HCl [pH 7.4], 5 mM EDTA, 1% NP-40, 10 mM Na 4 P 2 O 7 , 100 mM NaF, 2 mM sodium vanadate, 1 mM PMSF, 10 g of aprotinin per ml, and 10 g of leupeptin per ml). Then, 1.5 mg of total protein was subjected to immunoprecipitation with anti-Akt polyclonal antibodies for 1 h at 4°C. Immune complexes were washed three times in Akt lysis buffer and twice in kinase buffer (20 M NaCl, 1 mM sodium vanadate, 2 mM DTT) twice, the immunoprecipitates were incubated for 15 min at room temperature in a reaction mixture (30 l) containing 20 mM HEPES (pH 7.2), 10 mM MgCl 2 , 3 mM ␤-mercaptoethanol, 1 mg of BSA (MAPK) per ml, 50 M cold ATP, and 3 Ci of [␥-32 P]ATP. A total of 67 g of MBP (MAPK) per ml or 250 M S6 kinase substrate peptide (Upstate Biotech, Inc.) was used as a substrate. After the reaction was stopped with 10 l of 5ϫ SDS sample buffer (MAPK) or 10 l of stop buffer (S6 kinase, 1% BSA, 1 mM ATP, 0.6% HCl), the resulting supernatants (20 l) were resolved by electrophoresis on an SDS-12% gel (MAPK) or transferred to P81 filter paper (S6 kinase; Whatman, Hillsboro, Oreg.), followed by extensive washing in 75 mM phosphoric acid. Radioactivity incorporated into the substrate was determined by using the Bio-Rad Molecular Imager (MAPK) or by scintillation counting (S6 kinase).
[ 3 H]thymidine incorporation assay. The cells in log-phase growth were washed twice in RPMI 1640 containing 10% FBS, and 2 ϫ 10 5 cells were incubated in 1 ml of RPMI 1640 containing 10% in the absence or presence of various concentration of insulin or 5% WEHI for 48 h. H]thymidine (0.5 mCi; ICN) was spiked into the medium and incubated for 3 h. The cells were collected onto glass microfiber filters and washed three times with water to remove unincorporated nucleotide. Incorporation of labeled thymidine into DNA was quantitated by liquid scintillation counting.
Gel fragmentation assay. Cells (5 ϫ 10 6 ) in log-phase growth were incubated for 18 h in RPMI 1640 containing either 10% FBS with IL-3 (5% WEHI supplement) or 10% FBS with the indicated insulin doses. Cells were lysed in 400 l of Apo lysis buffer (10 mM Tris-HCl [pH 7.4], 10 mM EDTA, 0.2% Triton X-100), and then insoluble material was removed by centrifugation. The resulting supernatant was extracted once with an equal volume of phenol and once with phenol-chloroform (1:1). Fragmented DNA was collected by ethanol precipitation in the presence of glycogen carrier and then treated with RNase at 37°C for 30 min. Samples were loaded onto a 1.5% agarose gel and stained with ethidium bromide. The relative intensity of DNA bands was determined by using Molecular Analyst (Bio-Rad).
RESULTS
Isolation of the human IRS-4 open reading frame (ORF) and expression in 32D
IR cells. IRS-1, IRS-2, and IRS-4 have similar structures, including an NH 2 -terminal PH domain and a PTB domain, and multiple tyrosine phosphorylation sites that are expected to bind the SH2 domain of various signaling proteins ( Fig. 1) . Although the structural similarities suggest that IRS-1, IRS-2, and IRS-4 have certain common functions, recent observations suggest divergent signaling roles for each IRS protein. For instance, the number and type of SH2 domain-binding motifs differ among the IRS proteins, and mice null for IRS-1, IRS-2, or IRS-4 display radically different phenotypes (54) . Moreover, IRS-1 and IRS-2 are expressed ubiquitously in human tissues (8) , whereas human IRS-4 is expressed mainly in pituitary and thyroid glands and detected at lower levels in brain, spinal cord, trachea, and lymph nodes ( Fig. 2A) . IRS-4 transcripts were almost undetectable in the major insulin-sensitive tissues, suggesting that IRS-4 plays a unique physiologic role.
Because they contain few insulin receptors and no endoge- IR /IRS-4 clones were selected for further study based on apparently equal expression levels compared to IRS-1 and IRS-2 ( Fig. 2C) . Using the selected cell lines, insulin stimulated approximately equal amounts of tyrosine phosphorylation of IRS-1, IRS-2, and IRS-4 ( Fig. 2D ). Since the number of predicted tyrosine phosphorylation sites of each IRS protein was similar, the protein expression level of each IRS protein was thought to be comparable.
Insulin-stimulated phosphorylation of IRS proteins in 32D IR cells. We analyzed specific IRS protein immunoprecipitates from insulin-stimulated 32D IR cell lines or HEK293 cells by immunoblotting with PY20 in order to compare their rates of tyrosine phosphorylation. IRS-1, IRS-2, and IRS-4 were all maximally tyrosine phosphorylated during the first minute of insulin stimulation, with half-maximal phosphorylation occurring at or near a 1 nM insulin concentration ( Fig. 3A and B) . During prolonged insulin stimulation, the tyrosine phosphorylation of IRS-1 and IRS-2 decreased somewhat, whereas the tyrosine phosphorylation of IRS-4 remained elevated during 30 min of stimulation in both 32D
IR and HEK293 cells. Furthermore, the migration of IRS-1 and IRS-2 during SDS-PAGE was progressively retarded during insulin stimulation, whereas the migration of IRS-4 did not change in either 32D IR or HEK293 cells (Fig. 3A) . The retarded migration of IRS-1 and IRS-2 was attributed previously to increased insulin-stimulated serine phosphorylation, which may inhibit tyrosine phosphorylation and reduce downstream signaling by IRS proteins (18, 21) . Thus, IRS-4 may be less sensitive to heterologous serine phosphorylation than IRS-1 and IRS-2.
Insulin-stimulated association of IRS proteins with PI 3-kinase. Activation of PI 3-kinase by insulin regulates a variety of metabolic and mitogenic effects (41) . The binding of p85 isoforms to tyrosine phosphorylated YMXM motifs on IRS proteins is a principal pathway by which insulin activates PI 3-kinase (6, 40) . Before insulin stimulation, p85 barely associated with immunoprecipitates of IRS-1, IRS-2, or IRS-4 ( Fig. 3A  and B) . However, during the first minute of insulin stimulation, p85 binding to IRS-1 or IRS-2 increased approximately fivefold and remained elevated for 30 min; half-maximal stimulation occurred at a concentration of ca. 1 nM insulin ( Fig. 3C  and D) . By contrast, the association between p85 and IRS-4 in 32D IR or HEK293 cells was less sensitive to insulin (50% effective dose [ED 50 ] of Ͼ10 nM) and barely increased twofold ( Fig. 3C and D) . With isoform-specific antibodies, insulinstimulated association of p85␣ with IRS-4 was 10-fold weaker than with IRS-1 or IRS-2, and the association of p85␤ with IRS-4 was undetectable (Fig. 4A) . Consistent with these results, insulin barely stimulated the association of IRS-4 with isoform-independent p85 immunoprecipitates (␣p85 pan ), al- though p85 expression was approximately equal in each cell line tested (Fig. 4B) . Thus, p85␣ and p85␤ weakly engage IRS-4 compared to IRS-1 or IRS-2.
Insulin-stimulated activation of PI 3-kinase by IRS proteins. The binding of p85 to phosphorylated IRS-1 activates the associated PI 3-kinase catalytic subunit p110 (6, 40) . Consistent with the strong association of IRS-1 and IRS-2 with p85␣ and p85␤, insulin increased the PI 3-kinase activity 7-to 10-fold in ␣IRS-1 or ␣IRS-2 immunoprecipitates; by contrast, PI 3-kinase activity in IRS-4 immunoprecipitates increased about 2-fold (Fig. 5A ). To ensure that this difference did not merely reflect differing efficiencies of immunoprecipitation by the various ␣IRS protein antibodies, we assessed PI 3-kinase activity in PY20 immunoprecipitates. Before expression of IRS proteins, PI 3-kinase activity was barely detected in PY20 immunoprecipitates from untreated or insulin-stimulated 32D IR cells, which is consistent with the inability of the insulin receptor to engage PI 3-kinase directly (Fig. 5B) . As expected, PI-3 kinase activity was strongly associated with PY20 immunoprecipitates from 32D
IR cells expressing IRS-1 or IRS-2, whereas this activity was reduced 60% in 32D IR /IRS-4 cells. To measure directly whether the p85-associated PI 3-kinase was activated in 32D
IR cells expressing IRS-1, IRS-2, or IRS-4, we prepared specific immunoprecipitates of p85␣ from control and insulin-stimulated cells. As expected, PI 3-kinase in p85␣ immunoprecipitates was strongly activated by insulin in 32D IR cells expressing IRS-1 (Fig. 5C ). IRS-2 also mediated PI 3-kinase activation in 32D IR cells, although the response was less robust and less sensitive to insulin. Consistent with the reduced association of p85␣ with IRS-4, insulin weakly activated PI 3-kinase in p85␣ immunoprecipitates from 32D IR cells expressing IRS-4 (Fig. 5C) . Together, these results suggest that reduced activation of PI 3-kinase is a consequence of the weak interaction between IRS-4 and p85.
IRS-4 mediates insulin-stimulated PKB/Akt signaling cascade. PKB/Akt is an important signaling element downstream of PI 3-kinase (2). Activation of PI 3-kinase leads to the formation of PtdIns(3,4,5)P 3 and/or PtdIns(3,4)P 2 , thereby recruiting PKB/Akt to membranes and promoting its phosphorylation by other membrane-associated phospholipid-dependent kinases (PDKs). Phosphorylation of Ser 473 plays an important role in the activation of PKB/Akt, which is measured directly with a phospho-specific antibody (␣PhosphoAkt). Without IRS proteins, insulin had a negligible effect on the phosphorylation of Ser 473 in PKB/Akt. By contrast, after 10 min Ser 473 was maximally phosphorylated with equal insulin sensitivity in 32D IR in cells containing IRS-1, IRS-2, or IRS-4 ( Fig. 6A and B) .
Since PKB/Akt activation requires PI 3-kinase activation, we were initially surprised that IRS-4 mediated activation of PKB/ Akt as robustly as IRS-1 and IRS-2. To confirm this result, we measured PKB/Akt activity with histone H2B in ␣PKB immunoprecipitates prepared from untreated and insulin-stimulated 32D IR cell lines. Consistent with Ser 473 phosphorylation, insulin strongly activated PKB/Akt in 32D
IR cells expressing IRS-1, IRS-2, or IRS-4, whereas it failed to stimulate PKB in 32D IR cells without IRS proteins (Fig. 6C) . To confirm that PKB/Akt activation was mediated by products of the PI 3-kinase, 32D IR cells were incubated with LY294002, an inhibitor of PI 3-kinase. In each cell line tested, LY294002 inhibited insulin-stimulated activation of PKB/Akt, suggesting that the weak PI 3-kinase activation by IRS-4 might be sufficient to promote stimulation of PKB/Akt (Fig. 6D) .
The proapoptotic protein BAD is an important target of PKB/Akt. PKB/Akt catalyzed phosphorylation of BAD to link extracellular signals to the inhibition of apoptosis (13, 20) . During phosphorylation, BAD associates with 14-3-3, which prevents the formation of a proapoptotic heterodimer between BAD and Bcl-2/Bcl-XL (14, 16) . The phosphorylation of BAD was detected in 32D IR cells with a phosphospecific antibody. In 32D IR cells lacking IRS proteins, insulin weakly stimulated BAD phosphorylation and slightly promoted BAD association with Bcl-2 but not with 14-3-3 (Fig. 7A) . By contrast, the expression of IRS-1, IRS-2, or IRS-4 in 32D IR cells promoted strong insulin-stimulated BAD phosphorylation. Moreover, as expected, insulin promoted the concurrent association of 14-3-3 and dissociation of Bcl-2 from BAD (Fig. 7A) . Moreover, wortmannin inhibited the effects of insulin on the regulation of BAD in 32D
IR cells expressing IRS-1, IRS-2, or IRS-4, whereas it had no effect in cells lacking an IRS protein (Fig.  7B) .
Activation of p70 s6k by 32D IR cells. The p70 s6k is a serine/ threonine kinase involved in insulin-stimulated cell proliferation and protein synthesis which is activated by PI 3-kinasedependent phosphorylation of Thr 252 and Thr 412 (15, 23, 32, 37, 42, 53, 56, 59) . In order to compare the abilities of IRS-1, IRS-2, and IRS-4 to activate p70 s6k , we initially monitored the migration rate of p70 s6k during SDS-PAGE (32). Insulin stimulation (up to 30 min) reduced the migration rate of p70 s6k from 32D
IR cells expressing IRS-1 or IRS-2 but not from cells expressing IRS-4 (Fig. 8A) . These results suggest that insulin failed to activate p70 s6k in 32D IR /IRS-4 cells. We confirmed these results with immunoprecipitated p70 s6k by using in vitro kinase assays. Robust insulin-stimulated activation of p70 s6k was observed in 32D
IR cells expressing IRS-1 or IRS-2 cells but not in cells expressing IRS-4 (Fig. 8B) . Thus, during insulin stimulation, IRS-4 differentially activated p70 s6k and PKB/Akt in 32D IR cells.
Differential activation of the MAPK cascade by the various IRS proteins.
Each IRS protein contains a tyrosine phosphorylation site in an amino acid sequence motif predicted to bind the SH2 domain of Grb-2 (see Fig. 1, above) , an upstream mediator of p21 ras 3Erk kinase signaling (33) . While the insulin receptor mediates the insulin-stimulated activation of Erk kinases in the absence of IRS proteins (likely via the Shc3Grb-2 pathway), the recruitment of Grb-2 by IRS-1 enhances insulin-stimulated Erk kinase activation (33, 36, 43) . In order to assess differences in the regulation of this pathway among the various IRS proteins, we compared the abilities of IRS-1, IRS-2, and IRS-4 to bind Grb-2 and enhance the insulin-stimulated activity of Erk kinases in 32D IR cells. ␣Grb-2 immunoblotting of ␣IRS protein immunoprecipitates from insulin-stimulated 32D IR cell extracts revealed similar amounts of Grb-2 associated with IRS-1 and IRS-4 during maximal insulin stimulation; by contrast, approximately 40% less Grb-2 associated with IRS-2 ( Fig. 9A and B) . The weak association of IRS-2 with Grb-2 is consistent with previous results (46) .
We measured Erk kinase activity in ␣Erk immunoprecipitates prepared from cells stimulated for 5 min with various insulin concentrations. As previously shown, the IRS proteins were not required for insulin-stimulated Erk kinase activation in 32D
IR cells, although expression of IRS-1 or IRS-4 enhanced the insulin response ( Fig. 9C and D) . However, IRS-2 failed to enhance insulin-stimulated Erk kinase activity above the level measured in 32D IR cells lacking IRS proteins (Fig. 9C  and D) . Similar results were observed when Erk kinase activity was assessed by immunoblotting cell lysates with activated Erkspecific antiphosphorylated Erk antibodies (data not shown). Thus, IRS-1 and IRS-4 associated strongly with Grb-2 and enhanced insulin-stimulated Erk kinase activity. Differential signaling by IRS proteins on DNA synthesis and cell growth. The activation of both Erk and PI-3 kinase cascades are essential for insulin-stimulated proliferative signaling (29) . In the 32D IR cells, IRS proteins are required for insulinstimulated proliferation; however, previous work demonstrated that IRS protein-mediated activation of Erk kinases is not required (33, 59) . By contrast, the IRS protein-mediated activation of PI 3-kinase and its downstream mediators (e.g., PKB/Akt and p70 s6k ) are critical for proliferation. Since IRS-4 failed to bind p85-associated PI 3-kinase or activate p70 s6k , it may only weakly promote growth of 32D IR cells. To test this hypothesis, we measured insulin-stimulated [ 3 H]thymidine incorporation into DNA (a measure of proliferation) in the 32D IR cell lines (Fig. 10A) . As previously shown, insulin had little or no effect on thymidine incorporation in 32D IR cells (31, 51) . IRS-1 strongly promoted insulin-stimulated thymidine incorporation, with a half-maximal effect at a 0.3 nM insulin concentration; 32D IR /IRS-2 cells were 10-fold less sensitive to insulin, but the maximal response was the same (Fig. 10A) . By contrast, [ 3 H]thymidine incorporation in 32D IR /IRS-4 cells was both less sensitive to insulin and significantly less intense.
In order to confirm that the [ 3 H]thymidine incorporation data reliably reflected cell proliferation in the 32D IR cell lines, we measured proliferation by determining the absolute number of cells for each line during a 7-day interval in the presence or absence of IL-3 or insulin (Fig. 10B to D) . Consistent with the induction of apoptosis that occurs upon IL-3 withdrawal (59), all cells from all cell lines died within 3 to 5 days in the absence of IL-3 and insulin (Fig. 10B) . In the presence of IL-3, all cell lines increased approximately 1,000-fold over 7 days; however, three independent clones of 32D IR /IRS-4 cells proliferated slightly more slowly than the other lines (Fig. 10C) . As previously shown, insulin promoted proliferation of IL-3-deprived 32D
IR cells expressing IRS-1 or IRS-2, although the 32D IR /IRS-2 cells responded slightly less robustly than the 32D IR /IRS-1 cells; the replication of 32D IR /IRS-4 cells was weakly stimulated by insulin. Thus, the differing abilities of the IRS proteins to mediate the growth of 32D IR cells correlated strongly with the ability of the IRS-1 and IRS-2 to activate the p85-associated PI 3-kinase and p70 s6k , rather than the ability to activate PKB/Akt.
IRS-4 fails to mediate antiapoptosis in 32D
IR cells. The relative rates of cell division and death determine cell number. To assess the role of apoptosis, we examined the ability of the various IRS proteins to prevent DNA fragmentation in 32D IR cells incubated without IL-3. DNA from apoptotic cells characteristically displays a ladder of DNA fragments when analyzed by ethidium bromide-agarose gel electrophoresis, owing to the cleavage of genomic DNA between the ϳ200-bp nucleosome repeats (55) . By this assay, all 32D IR cell lines undergo apoptosis between 8 and 12 h in the absence of IL-3 or insulin (7, 28, 59) . As previously shown, insulin protected 32D (59); however, IRS-4 failed to inhibit apoptosis during insulin stimulation (Fig. 11A) .
IL-3 typically prevents apoptosis of 32D cells, but the level of DNA fragmentation was consistently elevated in four independent clones of 32D IR /IRS-4 cells even during incubation with IL-3; upon IL-3 withdrawal, DNA fragmentation was not inhibited by insulin (Fig. 11A) . Thus, not only did IRS-4 poorly inhibit apoptosis during growth in insulin, it slightly increased apoptosis during IL-3-dependent growth. This result is even more striking compared to 32D IR cells expressing PP IRS-1 . PP IRS-1 lacks the COOH tail of tyrosine phosphorylation sites and contains only the NH 2 -terminal PH and PTB domains of IRS-1 (59). PP IRS-1 fails to bind or activate PI 3-kinase but inhibits apoptosis of 32D IR cells during insulin stimulation. Compared to intact IRS-1, PP IRS-1 effectively inhibited apoptosis of 32D IR cells, although it was about 10-fold less sensitive to insulin (Fig. 11B and C) . Thus, signaling pathways engaged by the NH 2 apoptosis during insulin stimulation may not be engaged by the PH and PTB domains of IRS-4.
DISCUSSION
Tyrosine phosphorylated IRS proteins bind SH2 domaincontaining proteins to assemble complexes that mediate the insulin response. The four known IRS proteins share similar overall structure, including an NH 2 -terminal PH domain and a PTB domain, as well as a COOH-terminal tail with numerous tyrosine phosphorylation sites (17, 25, 47, 48) . The common structure suggests some similarity of function among the IRS proteins. Indeed, each IRS protein binds various SH2 proteins following tyrosine phosphorylation by the insulin receptor (58) . Beyond this basic paradigm, the details of signaling specificity diverge somewhat. The number, placement, and even presence of tyrosine phosphorylation motifs within the tails of IRS proteins differ; the COOH-terminal tail of IRS-3 has one-third the length of the other IRS proteins; and IRS-4 lacks both consensus SHP-2 binding motifs present in IRS-1, IRS-2, and IRS-3. In terms of function, the various IRS proteins appear to differ, as well. IRS-2 cannot substitute for IRS-1 in fibroblasts lacking IRS-1 (9) . Similarly, the phenotypes of mice null for the various IRS proteins vary widely. The IRS-1 null is small and insulin resistant, although never diabetic, whereas the IRS-2 null mouse is diabetic due to insulin resistance and ␤-cell failure. No phenotype has yet been ascribed to the IRS-3 and IRS-4 null mice (27) .
While IRS-1 and IRS-2 are expressed relatively ubiquitously, expression of IRS-4 is restricted almost exclusively to the pituitary gland and brain; such differences in expression pattern provide one possible explanation for specificity. However, the overlapping expression pattern suggests that IRS proteins possess distinct functions as well. Indeed, by contrasting the functions of IRS-1, IRS-2, and IRS-4 in 32D cells, several differences in the signal transmission emerge. IRS-1 and IRS-4 strongly bind Grb-2 and enhance the activation of the MAPK during insulin stimulation; IRS-2 performs these functions weakly. During insulin stimulation, IRS-1 and IRS-2 mediate antiapoptosis, DNA synthesis, and replication of IL-3-deprived 32D IR ; however, under these conditions IRS-4 expression fails to inhibit apoptosis of 32D IR cells and, as a consequence, promotes cell replications weakly. Moreover, in the presence of IL-3, IRS-4 expression promotes apoptosis through an unknown mechanism. Thus, each IRS protein is a distinct molecular platform coupling insulin receptors to a unique cohort of regulatory signals.
The class I PI 3-kinase is composed of a catalytic (p110␣, p110␤, and p110␦) subunit which heterodimerizes with one of many SH2 domain-containing regulatory subunits (p85␣, p85␤, p55␣, and p55 PIK ). The SH2 domain-containing regulatory subunits recognize tyrosine phosphorylated YXXM motifs in signaling proteins such as IRS-1 and IRS-2. Occupancy of the SH2 domains by these motifs activates the associated p110 catalytic subunit (6) . These interactions cause a strong association of activated PI 3-kinase with the IRS proteins and mediate the stimulation of PKB/Akt, PKC, and p70 s6k and other serine/threonine kinases (29, 30, 32, 33, 35, 49 ; M. G. Myers, Jr., Y. Zhang, L. Yenush, et al., abstr., Diabetes 44:49A, 1995) . PI 3-kinase may also interact positively with the p21 ras pathway, although we have not detected such an interaction in the 32D cells (32, 33, 39) .
IRS-4 contains at least six YXXM motifs that should bind p85␣ and/or p85␤ (17) . In contrast to IRS-1 and IRS-2, IRS-4 binding to p85 is barely detected during insulin stimulation; and while IRS-4 binds p85␣ weakly, it completely fails to bind p85␤. Furthermore, IRS-4 lacks the COOH-terminal SHP-2 binding sites, which should enhance the binding and activation of PI 3-kinase and PI 3-kinase-dependent responses by IRS-4 (31). Thus, the poor activation of PI 3-kinase by IRS-4 may arise from the inability of the insulin receptor to phosphorylate the YXXM motifs in IRS-4. Since YXXM motifs are ideal phosphorylation sites for the insulin receptor in vitro (44, 45) , the tail of IRS-4 may have a conformation that precludes the phosphorylation of its YXXM motifs by the insulin receptor. In light of our results, a direct analysis of tyrosine phosphorylation site utilization in IRS-4 needs to be conducted.
Although IRS-4 weakly binds p85␣ and fails to bind p85␤, it promotes the PKB/Akt signaling pathway during insulin stimulation. This effect is sensitive to LY294002, an inhibitor of PI 3-kinase, indicating that products of the PI 3-kinase are required. While we cannot exclude the possibility that constitutive levels of PI 3-kinase products in combination with unique IRS-4-mediated signals are sufficient to promote activation of PKB/Akt during insulin stimulation, our results suggest that IRS-4 stimulates sufficient PI 3-kinase activity to activate PKB/ Akt. Some PI 3-kinase activity is immunoprecipitated from insulin-stimulated cells with antibodies against IRS-4 or phosphotyrosine (PY20), but this does not appear to be associated with p85␣ or p85␤. The interaction between IRS-4 and p85 is so weak that ␣p85 immunoprecipitates from insulin-stimulated cells do not contain increased PI 3-kinase activity, as usually observed in cells expressing IRS-1 or IRS-2. Perhaps IRS-4 fails to bind to both SH2 domains in p85, which is ordinarily required for full activation (40) . Nevertheless, the activation of PI 3-kinase by association with IRS-4 is significantly reduced, although sufficient to fully stimulate PKB/Akt as evaluated by our in vitro kinase assays and BAD phosphorylation in cells.
Although IRS-4 mediates insulin-stimulated activation of PKB/Akt and BAD phosphorylation, it fails promote the activation of p70 s6k . This unexpected result is one of the clearest demonstrations of the different signaling capacity of IRS-4 compared to IRS-1 or IRS-2. Previous reports revealed that YMXM motifs in IRS-1 are required for insulin to stimulated p70 s6k , suggesting that a direct association between PI 3-kinase and IRS-1 is required (32, 35) . Although increased PI 3-kinase activity is detected in antiphosphotyrosine immunoprecipitates from IRS-4-expressing 32D IR cells, this is poorly associated with p85, suggesting that p85-associated PI 3-kinase is essential for promoting activation of p70 s6k during insulin stimulation. Thus, the regulation of p70 s6k diverges early from the pathways that activate PKB/Akt, which is activated by non-p85-associated PI 3-kinase and IRS-4.
The regulation of PKB/Akt involves the recruitment of several kinases to the plasma membrane. The PH domain in PKB/Akt binds to PI 3-kinase products, recruiting PKB/Akt to the plasma membrane and exposing it to membrane-associated phospholipid-dependent kinases (1). Phospholipid-dependent kinase-1 (PDK1) also associates with the plasma membrane through interaction of its PH domain with PI 3-kinase products; membrane-associated PDK1 catalyzes phosphorylation of Thr 308 in PKB/Akt (3, 50) . The phosphorylation of Ser 473 , which is required for full activation, is thought to be catalyzed by a similar membrane-associated kinase, called PDK2 (2). Thus, activation of PKB/Akt depends on PI 3-kinase activity to recruit interacting kinases to the plasma membrane. This regulatory mechanism may be independent of the exact mechanism that stimulates the production of phospholipids.
PI 3-kinase activity is also critical for the activation of p70 s6k . The PI 3-kinase-dependent phosphorylation of Thr  252 and  Thr  412 fully activates p70   s6k , although the exact kinases involved are not well defined (11, 52 s6k while mediating activation of PKB/Akt normally. It is possible that IRS-1 or IRS-2 mediate PI 3-kinase-independent signals that are not engaged by IRS-4 but which are essential for activation of p70 s6k . However, this mechanism is unlikely because the Drosophila insulin receptor or a chimeric mammalian insulin receptor containing an extended tail of YXXM motifs that bind p85-associated PI 3-kinase and activate p70 s6k without IRS proteins (56, 59) . Full activation of p85-associated PI 3-kinase may be the critical step in p70 s6k activation. 32D cells are ordinarily dependent on IL-3 for long-term growth, since withdrawal of IL-3 induces apoptosis within 12 h (59). In the absence of IRS proteins, IL3-deprived 32D IR cells undergo apoptosis and fail to proliferate during insulin stimulation. In contrast, insulin strongly stimulates DNA synthesis and suppresses apoptosis in 32D
IR cells expressing IRS-1 or IRS-2. However, both insulin responses are significantly reduced in 32D IR cells expressing IRS-4. The inability of IRS-4 to form a complex with PI 3-kinase and activate p70 s6k may in part explain the weak insulin-stimulated DNA synthesis promoted by IRS-4.
Persistent apoptosis in insulin-or IL3-treated 32D IR /IRS-4 cells is unexpected since signaling pathways that promote survival are thought to be downstream of PKB/Akt. BAD is one of the cellular targets that PKB/Akt phosphorylates to protect cultured neurons from apoptosis (13) . Consistent with this hypothesis, insulin stimulates wortmannin-sensitive BAD phosphorylation equally in 32D
IR cells expressing IRS-1, IRS-2, or IRS-4. Moreover, Bcl-2 dissociates from BAD and 14-3-3 associates with BAD in each of these cell lines, suggesting that BAD phosphorylation may not be the critical step to inhibit apoptosis in IL-3-deprived 32D IR cells. IRS-4 fails to activate p70 s6k , but the possibility that this is essential for antiapoptosis is inconsistent with our previous results. Our previous work with 32D cells expressing mammalian insulin receptor chimeras that directly bind p85 suggests that activation of PI 3-kinase, PKB/Akt, and p70 s6k is not sufficient to inhibit apoptosis during IL-3 withdrawal (56, 59) . Moreover, a truncated IRS-1 molecule (PP IRS1 ) lacking the entire tail of tyrosine phosphorylation sites just after the PTB domain inhibits apoptosis during insulin stimulation (59) . In these cells, p70 s6k was not activated after insulin stimulation for up to 60 min, although PKB/Akt was weakly activated (59) . Therefore, activation of p70 s6k is unlikely to be involved in insulin-induced antiapoptosis. Moreover, like the expression of IRS-4 in 32D IR cells, direct binding of p85-associated PI 3-kinase to these chimeric insulin receptors promotes apoptosis during IL-3 stimulation and accelerates apoptosis during IL-3 withdrawal (56, 59) . Interestingly, IRS-1 promotes survival of 32D cells expressing the chimeric insulin receptors, suggesting that the presence of IRS-1, but not necessarily the activation of PI 3-kinase-dependent pathways, is a critical element for insulin-stimulated antiapoptosis.
The signaling pathways regulated by IRS-1 to inhibit apoptosis during insulin stimulation may be independent of PI 3-kinase. A mutant IRS-1 molecule lacking all 18 tyrosine phosphorylation sites (IRS-1 F18 ) reduces significantly the ability of insulin to stimulate proliferation of 32D IR cells; however, IRS-1 F18 inhibits apoptosis of IL-3-deprived 32D IR cells during insulin stimulation (L. Yenush, M. F. White, et al., unpublished data). The replacement of a few PI 3-kinase binding motifs increases the sensitivity of the signal to insulin, suggesting that products of the PI 3-kinase may amplify the otherwise phosphotyrosine-independent antiapoptotic signal by recruiting essential elements to the plasma membrane. However, it should be kept in mind that p85 binding sites are not required for the biological response.
In summary, IRS-4 either fails to mediate an antiapoptotic (PI 3-kinase-independent) signal mediated by other IRS-1 or IRS-2 or it promotes a proapoptotic signal. Given the increased rate of apoptosis exhibited by 32D IR /IRS-4 cells when grown in IL-3, the latter explanation might be correct. The phenotypes of IRS-1, IRS-2, and IRS-4 in 32D IR cells highlight dramatically the functional differences among the various IRS proteins. The ability of IRS-4 to mediate activation of PKB/ Akt in the absence of p70 s6k activation suggests an antiapoptotic mechanism that diverges at the level of the IRS proteins. A full understanding of these pathways has certain physiological significance, since IRS-2 is critical for pancreatic ␤-cell proliferation and IRS-1 is essential for somatic cell growth.
